Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
The peptides lose stability and potency when mixed
Retatrutide's Phase 2 experience follows the class pattern: GI events are the dominant adverse-event category and the burden scales with dose
Batch-Tested for Solubility: To protect your research integrity, we pull random samples from every batch at our Hamilton hub
Retatrutide as a single agent outperforms cagrilintide as a single agent by a significant margin
Choose the route Decide on your primary goal: cosmetic/topical vs systemic/injectable
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
